Results 271 to 280 of about 574,105 (363)

Practicing Repurposing in the Pharmaceutical Industry: Uncovering New Uses for Potential Resources

, 2019
Burcu Küçükkeles
openalex   +2 more sources

Academia-pharmaceutical industry linkage: An academic perspective. [PDF]

J Pharm Policy Pract
Mubarak Z, Abbas N, Hashmi FK, Husnain SZ, Bukhari NI.   +4 more
europepmc   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

Regulation of brands in the Indian pharmaceutical industry in the 1960s: Examination of the Tariff Commission Report, 1968

Manu Kanchan
openalex   +1 more source

Financial Performance of Pharmaceutical Industry in Bangladesh with Special Reference to Square Pharmaceuticals Ltd.

, 2014
Iosr Journals, Dr. Md. Mushfiqur Rahman
openalex   +1 more source

A Database on Antibiotics and Antibiotic Resistance in Wastewater and Solid Waste from Pharmaceutical Industry Based on a Systematic Review. [PDF]

China CDC Wkly
Wu J, Han Z, Ma X, Su M, Hamidian AH, Zhang Y, Yang M.   +6 more
europepmc   +1 more source

Harnessing Next‐Generation 3D Cancer Models to Elucidate Tumor‐Microbiome Crosstalk

Advanced Healthcare Materials, EarlyView.
Centralizes the microbiome within 3D tumor‐microbiome model platforms, including spheroids, organoids, 3D‐bioprinted constructs, and microfluidic chips, each enabling structured host‐tumor‐microbe studies. These systems support bacterial colonization, facilitating investigation of microbial impacts on tumor growth, immunity, and therapy. The microbiome
Marina Green Buzhor, Giuseppe Longobardi, Or Kandli, Anne Krinsky, Opal Avramoff, Anshika Katyal, Koren Salomon, Adan Miari, Dana Venkert, Tania T. Barnatan, América García Alvarado, Shahar Greenberg, Ronit Satchi‐Fainaro   +12 more
wiley   +1 more source

"I never thought of it as payment": Qualitative evaluation of workshops with advanced practice registered nurses on pharmaceutical industry payment reporting. [PDF]

J Am Assoc Nurse Pract
Grundy Q, Rudner N, Klein T, Ladd E, Hart D, MacIsaac M, Bero L.   +6 more
europepmc   +1 more source

Methotrexate‐Loaded Liposomal Formulation Enables 6‐Week Sustained Intraocular Therapeutic Drug Release in a Porcine Model

Advanced Healthcare Materials, EarlyView.
A liposomal formulation for methotrexate enables minimally invasive, sustained intraocular drug delivery for over six weeks with a single injection. Developed for treating intraocular diseases like lymphoma and PVR, it offers excellent biocompatibility in vivo in a porcine model.
Maximilian Hammer, Lea Skrzypczyk, Sabrina Wohlfart, Bryan Calder Ackermann, Ludwig Geisweid, Simon William Pohl, Margarita Karaivanova, Jonathan Herth, Victor Aristide Augustin, Alexander Studier‐Fischer, Tina Sackmann, Leon Kaulen, Anna Steyer, Walter Mier, David H Steel, Kanmin Xue, Gerd Uwe Auffarth, Philipp Uhl   +17 more
wiley   +1 more source

Conclusions of clinical trials assessing monoclonal antibodies and sponsored by pharmaceutical industry: a meta-research study. [PDF]

Rev Assoc Med Bras (1992)
Ornelas RC, Pazini DS, Pacheco RL, Martimbianco ALC, Riera R.   +4 more
europepmc   +1 more source